Corcept Therapeutics Incorporated (CORT)
Oxford Ledge is still expanding full research coverage of CORT. A live quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
A pharmaceutical company developing cortisol-modulating medications for serious metabolic, endocrine, cancer, and neurologic disorders.
SEC filings
- 8-K Other material event; Financial statements and exhibits 2026-06-17
- 8-K Other material event 2026-06-03
- 8-K Departure/election of directors or officers; Shareholder vote results; Financial statements and exhibits 2026-05-28
- 10-Q Quarterly financial report (unaudited) 2026-04-30
- 8-K Results of operations / financial condition; Regulation FD disclosure; Financial statements and exhibits 2026-04-30
Source: SEC EDGAR.
Insider activity
5 recent insider (SEC Form 4) filings on record for CORT. View the transactions in the terminal.
Source: SEC EDGAR (Form 4).
- Open CORT in the Oxford Ledge terminal — live quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.